Sanofi France chief sees coronavirus vaccine priced below 10 euros
PARIS (Reuters) - A coronavirus vaccine that Sanofi (SASY.PA) is developing with Britain’s GlaxoSmithKline (GSK.L) is likely to be priced at less than 10 euros ($11.80) per shot if it is approved for use, Sanofi’s chief in France said on Saturday.
“The price is not totally set ... We are assessing production costs for the coming months ... We will be below 10 euros,” Olivier Bogillot told France Inter radio.